WO2011142530A3 - 피부 충전제 조성물 - Google Patents

피부 충전제 조성물 Download PDF

Info

Publication number
WO2011142530A3
WO2011142530A3 PCT/KR2011/001556 KR2011001556W WO2011142530A3 WO 2011142530 A3 WO2011142530 A3 WO 2011142530A3 KR 2011001556 W KR2011001556 W KR 2011001556W WO 2011142530 A3 WO2011142530 A3 WO 2011142530A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
skin
injection
dermal filler
present
Prior art date
Application number
PCT/KR2011/001556
Other languages
English (en)
French (fr)
Other versions
WO2011142530A2 (ko
Inventor
조강선
Original Assignee
조시영
조재영
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 조시영, 조재영 filed Critical 조시영
Priority to AU2011251138A priority Critical patent/AU2011251138B2/en
Priority to JP2013506062A priority patent/JP2013524927A/ja
Priority to EP11780747.9A priority patent/EP2570141B1/en
Priority to RU2012146876/15A priority patent/RU2012146876A/ru
Priority to BR112012028232A priority patent/BR112012028232B1/pt
Priority to US13/640,697 priority patent/US9242030B2/en
Priority to CA2794017A priority patent/CA2794017C/en
Publication of WO2011142530A2 publication Critical patent/WO2011142530A2/ko
Publication of WO2011142530A3 publication Critical patent/WO2011142530A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 분자량이 30,000 이상의 100,000 이하인 가교된 덱스트란을 주성분으로 단독으로 사용하여도 피부 충전제의 적용부위의 신속한 확대와 부드러운 촉감을 유지할 수 있고, 시술 전에 알러지 반응검사 등의 전처치가 필요 하지 않으며, 비용이 저렴하며, 체내에서 쉽게 분해, 흡수되지 않아 시술에 의한 부피확대효과를 더욱 장기간 안정적으로 유지할 수 있어서 20cc이상의 많은 양의 피부 충전제의 주입을 필요로 하는 주사음경확대와 같은 수술에서도 사용하기 적합하고, 제조공정이 보다 단순하여 실용화가 더 용이한 효과가 있으며, 피부아래로 주입시 감촉이 부드러워 음경의 피부 뿐만 아니라 안면을 포함한 인체의 다른 광범위한 부위의 피부에도 사용이 가능한 새로운 피부충전제 조성물 및 그 제조방법에 관한 것이다.
PCT/KR2011/001556 2010-05-11 2011-03-07 피부 충전제 조성물 WO2011142530A2 (ko)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2011251138A AU2011251138B2 (en) 2010-05-11 2011-03-07 Dermal filler composition
JP2013506062A JP2013524927A (ja) 2010-05-11 2011-03-07 皮膚充填剤組成物
EP11780747.9A EP2570141B1 (en) 2010-05-11 2011-03-07 Dermal filler composition
RU2012146876/15A RU2012146876A (ru) 2010-05-11 2011-03-07 Композиция наполнителя для кожи
BR112012028232A BR112012028232B1 (pt) 2010-05-11 2011-03-07 composição de preenchedor dérmico
US13/640,697 US9242030B2 (en) 2010-05-11 2011-03-07 Dermal filler composition
CA2794017A CA2794017C (en) 2010-05-11 2011-03-07 Dermal filler composition comprising cross-linked dextran having a molecular weight of 30,000 to 100,000

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100043753A KR101003331B1 (ko) 2010-05-11 2010-05-11 피부 충전제 조성물
KR10-2010-0043753 2010-05-11

Publications (2)

Publication Number Publication Date
WO2011142530A2 WO2011142530A2 (ko) 2011-11-17
WO2011142530A3 true WO2011142530A3 (ko) 2012-01-05

Family

ID=43513243

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/001556 WO2011142530A2 (ko) 2010-05-11 2011-03-07 피부 충전제 조성물

Country Status (11)

Country Link
US (1) US9242030B2 (ko)
EP (1) EP2570141B1 (ko)
JP (1) JP2013524927A (ko)
KR (1) KR101003331B1 (ko)
CN (1) CN102247618B (ko)
AU (1) AU2011251138B2 (ko)
BR (1) BR112012028232B1 (ko)
CA (1) CA2794017C (ko)
HK (1) HK1163562A1 (ko)
RU (1) RU2012146876A (ko)
WO (1) WO2011142530A2 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018203714A1 (en) * 2017-03-09 2018-09-27 Colin Campbell Marshall Moore Improved Phalloplasty Method
AU2017101856B4 (en) * 2017-05-02 2021-08-05 Oates & Family Pty Ltd Procedure for Penile Girth Enhancement
CN108653817B (zh) * 2018-05-24 2021-02-02 上海其胜生物制剂有限公司 一种新型胶原刺激剂的制备方法
CN111558085A (zh) * 2020-06-16 2020-08-21 红色未来科技(北京)有限公司 一种面部填充剂及其制备方法
KR102430642B1 (ko) * 2020-07-03 2022-08-16 주식회사 메피온 필러 조성물 및 그 제조 방법
CN113041397A (zh) * 2021-04-08 2021-06-29 红色未来科技(北京)有限公司 一种含有交联葡聚糖的面部填充剂及其制备方法
CN113244450A (zh) * 2021-05-31 2021-08-13 美卓(杭州)医疗科技有限公司 一种用于手部抗衰的活性填充剂及其制备方法
CN114225117A (zh) * 2021-11-08 2022-03-25 红色未来科技(北京)有限公司 一种含有交联葡聚糖的综合性面部填充剂及其制备方法
CN114146221A (zh) * 2021-12-09 2022-03-08 杭州帕莱拉医疗科技有限公司 一种可注射右旋糖苷水凝胶微球填充剂及其制备方法
CN115252896A (zh) * 2022-08-11 2022-11-01 成都恒美盛生物科技有限公司 一种面部填充剂生产用物料混合方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04303445A (ja) * 1991-03-29 1992-10-27 Nippon Zeon Co Ltd 創傷被覆材
US5502042A (en) * 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US6060461A (en) * 1999-02-08 2000-05-09 Drake; James Franklin Topically applied clotting material
US20040096410A1 (en) * 2002-07-29 2004-05-20 Maley Joseph C. Methods and compositions for treatment of dermal conditions
KR100759091B1 (ko) * 2006-12-13 2007-09-17 조강선 피부 충전제 조성물
KR20090043973A (ko) * 2007-10-30 2009-05-07 조강선 피부 충전제 조성물
KR20090104811A (ko) * 2006-12-28 2009-10-06 챠오잉 쟈오 상처 치료 개선용 약제 제조를 위한 고장액 조성물의 이용

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
FR2764514B1 (fr) 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
US20040235791A1 (en) 2002-01-25 2004-11-25 Gruskin Elliott A. Scar reduction
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
CN101027065A (zh) 2004-06-15 2007-08-29 陈献 磷脂组合物及其制备和使用方法
SE0600091L (sv) 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04303445A (ja) * 1991-03-29 1992-10-27 Nippon Zeon Co Ltd 創傷被覆材
US5502042A (en) * 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US6060461A (en) * 1999-02-08 2000-05-09 Drake; James Franklin Topically applied clotting material
US20040096410A1 (en) * 2002-07-29 2004-05-20 Maley Joseph C. Methods and compositions for treatment of dermal conditions
KR100759091B1 (ko) * 2006-12-13 2007-09-17 조강선 피부 충전제 조성물
KR20090104811A (ko) * 2006-12-28 2009-10-06 챠오잉 쟈오 상처 치료 개선용 약제 제조를 위한 고장액 조성물의 이용
KR20090043973A (ko) * 2007-10-30 2009-05-07 조강선 피부 충전제 조성물

Also Published As

Publication number Publication date
CA2794017A1 (en) 2011-11-17
AU2011251138A1 (en) 2012-10-11
CN102247618A (zh) 2011-11-23
US20130053453A1 (en) 2013-02-28
HK1163562A1 (en) 2012-09-14
US9242030B2 (en) 2016-01-26
WO2011142530A2 (ko) 2011-11-17
CA2794017C (en) 2014-11-18
EP2570141A2 (en) 2013-03-20
BR112012028232B1 (pt) 2018-09-04
JP2013524927A (ja) 2013-06-20
KR101003331B1 (ko) 2010-12-23
AU2011251138B2 (en) 2013-11-14
EP2570141B1 (en) 2018-07-25
EP2570141A4 (en) 2014-08-06
RU2012146876A (ru) 2014-06-20
CN102247618B (zh) 2014-06-18

Similar Documents

Publication Publication Date Title
WO2011142530A3 (ko) 피부 충전제 조성물
TN2009000124A1 (en) Injectable depot composition and its process of preparation
MY153641A (en) Dermal filler composition
UA95660C2 (ru) Имплантат, который инъектируется, для защиты дермы от свободных радикалов, набор в форме шприца, который содержит такой имплантат, применение гиалуроновой кислоты для изготовления имплантата, способ получения и применения имплантата, косметический способ заполнения морщин и/или мелких морщин
Freytes et al. Effect of storage upon material properties of lyophilized porcine extracellular matrix derived from the urinary bladder
WO2007059979A3 (en) Allergy treatment by epicutaneous allergen administration
TW200616643A (en) Ophthalmic compositions and methods for treating ophthalmic conditions
EP2097835A4 (en) PATIENT-BASED PARAMETER GENERATION SYSTEMS FOR MEDICAL INJECTION METHODS
EP2341953A4 (en) HYDROGELS FOR INCREASING AND REPAIRING VOCAL STRINGS AND SOFT TISSUE
RU2015118969A (ru) Дермальная инъецируемая стерильная композиция
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
CA2734560C (en) Composite extracellular matrix materials and medical products formed therefrom
WO2010008893A3 (en) Anchor systems and methods
BR112012030455A2 (pt) processo para fabricar uma composição hesmostática seca e estável, método para dispensar uma composição hemostática a um sítio alvo em um corpo do paciente, recipiente acabado final, método para prover uma composição hemostática pronta para uso, e, kit para administrar uma composição hemostática
WO2008001377A3 (en) Needleless injections for administering compositions to the skin
MX2010003019A (es) Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
WO2013106385A3 (en) System and methods for determining tissue elasticity
NZ607306A (en) Compounds and methods for skin repair
MX2016008496A (es) Composiciones de acido graso de liberacion controlada para usarse en recontruccion corporal y formacion del cuerpo.
Leonardis et al. Use of cross-linked carboxymethyl cellulose for soft-tissue augmentation: preliminary clinical studies
WO2009134054A3 (en) Heparin-conjugated fibrin gel and method and kit for preparing the same
WO2009079507A3 (en) Crosslinked hydrogels
WO2009120886A3 (en) Design and manufacturing of bioactive implanted surgical fixation devices using injection molding of gradient cellular strucures
NZ599395A (en) Antisense formulation
WO2007143682A3 (en) Systems and methods of delivering fluids to a patient of varying concentration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11780747

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2011251138

Country of ref document: AU

Ref document number: 8172/DELNP/2012

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2794017

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2011251138

Country of ref document: AU

Date of ref document: 20110307

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13640697

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2011780747

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2013506062

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12012502113

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 1201005694

Country of ref document: TH

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2012146876

Country of ref document: RU

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012028232

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012028232

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20121105